4.7 Article

Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda

Related references

Note: Only part of the references are listed.
Article Oncology

Survival Impact and Cost-Effectiveness of a Multidisciplinary Tumor Board for Breast Cancer in Mozambique, Sub-Saharan Africa

Mariana Brandao et al.

Summary: The implementation of multidisciplinary tumor boards (MTBs) in Mozambique significantly decreased mortality among patients with early breast cancer and proved to be cost-effective. These findings emphasize the importance of scaling up MTBs in developing countries to improve patient outcomes.

ONCOLOGIST (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis

Catherine Duggan et al.

Summary: Some countries have seen significant reduction in breast cancer mortality rates through increased coverage of essential health services and higher number of public cancer centers. Early diagnosis programs are crucial for improving breast cancer outcomes.

LANCET ONCOLOGY (2021)

Editorial Material Oncology

Global Precision Oncology: A Call to Action on Expanding Access to Targeted Cancer Therapies

Maheetha Bharadwaj et al.

Summary: The article calls for improving access to precision oncology therapies in lower- and middle-income countries, highlighting lack of diagnostic ability, trained providers, and drug availability as significant barriers to cancer care delivery. It draws upon lessons from international efforts in oncology and infectious disease to make this urgent call to action.

ONCOLOGIST (2021)

Article Oncology

Increasing access to quality anticancer medicines in low- and middle-income countries - the experience of Uganda

Godfrey Osinde et al.

Summary: Cancer is a leading cause of death worldwide, especially in low-and middle-income countries in Africa, Asia, and Central and South America. Global expenditure on anticancer medicines has been increasing and is estimated to reach $200 billion by 2022. The Uganda Cancer Institute has successfully improved access to cancer medicines through a cost-saving procurement system, achieving significant cost savings and exceeding availability targets.

FUTURE ONCOLOGY (2021)

Article Health Care Sciences & Services

A framework policy analysis of national health insurance policymaking in sub-Saharan Africa

Amy Roll et al.

Summary: This research analyzed policies from four sub-Saharan African countries on the establishment of National Health Insurance (NHI) schemes and found significant variations in policy types and decision-making authority. While Ministries of Health retained some decision-making power, NHIs were often delegated authority in important areas such as financing mechanisms and provider payments.

HEALTH POLICY AND PLANNING (2021)

Review Public, Environmental & Occupational Health

Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature

Phyllis Ocran Mattila et al.

Summary: In low- and middle-income countries, there are significant disparities in pricing, availability, and affordability of anti-cancer medicines, leading to treatment abandonment due to low patient purchasing power. Multiple stakeholders need to implement multi-pronged policy and program approaches to ensure access to cancer medicines.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Health Care Sciences & Services

Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa

Phyllis Ocran Mattila et al.

Summary: The study examines the prices of cancer medicines for the three most common cancers in the private healthcare sector of South Africa, using WHO/HAI methodology. The results show significant variations in prices and affordability levels across different cancer medications.

BMC HEALTH SERVICES RESEARCH (2021)

Review Oncology

Hepatocellular Carcinoma in Sub-Saharan Africa

V. V. Pavan Kedar Mukthinuthalapati et al.

Summary: More than 80% of hepatocellular carcinoma cases occur in sub-Saharan Africa and East Asia, with chronic hepatitis B virus infection being the most common risk factor in SSA. Co-infection of HIV and HBV increases the risk of developing HCC in SSA.

JCO GLOBAL ONCOLOGY (2021)

Article Health Policy & Services

Challenges faced by cancer patients in Uganda: Implications for health systems strengthening in resource limited settings

Annet Nakaganda et al.

Summary: The Uganda Cancer Institute is the only comprehensive cancer treatment center in Uganda, with many cancer patients facing challenges in receiving treatment due to poor economic conditions and limited knowledge about their disease and treatment. To improve patient experience, establishing regional cancer centers, ensuring reliable supply of cancer medicines, and integrating navigation programs into cancer care are crucial recommendations. Strengthening the entire health system, particularly in cancer service delivery, should remain a top priority for Uganda and other resource-limited settings.

JOURNAL OF CANCER POLICY (2021)

Editorial Material Hematology

Improving outcomes for non-Hodgkin lymphoma in Sub-Saharan Africa: where to start?

Matthew S. Painschab et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Review Public, Environmental & Occupational Health

Health systems influence on the pathways of care for lung cancer in low- and middle-income countries: a scoping review

Ugochinyere I. Nwagbara et al.

GLOBALIZATION AND HEALTH (2020)

Review Medicine, General & Internal

Routes to diagnosis of symptomatic cancer in sub-Saharan Africa: systematic review

Tanimola Martins et al.

BMJ OPEN (2020)

Article Public, Environmental & Occupational Health

Availability, Costs and Stock-Outs of Essential NCD Drugs in Three Rural Rwandan Districts

Jean Paul Mukundiyukuri et al.

ANNALS OF GLOBAL HEALTH (2020)

Review Gastroenterology & Hepatology

Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes

Akwi W. Asombang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Article Health Care Sciences & Services

Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future

Omondi Michelle Atieno et al.

JOURNAL OF MEDICAL ECONOMICS (2018)

Article Multidisciplinary Sciences

Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study

Monica Adhiambo Onyango et al.

PLOS ONE (2018)

Article Public, Environmental & Occupational Health

Essential medicines for cancer: WHO recommendations and national priorities

Jane Robertson et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2016)

Review Oncology

Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes

Lawrence N. Shulman et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Article Multidisciplinary Sciences

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand

Rosarin Sruamsiri et al.

PLOS ONE (2015)